ClinicalTrials.gg
Not yet recruitingNCT07169110SPIN-NAUpdated Dec 18, 2025

Study of the Interprofessional Reproducibility of a Clinical Observation Scale for the Development of Very Premature Infants

An observational study in Prematurity, sponsored by University Hospital, Toulouse. Not yet recruiting at 1 site in France. Open to participants aged 1 Month to 6 Months. Per ClinicalTrials.gov, last updated 2025-12-18.

Sponsored by University Hospital, Toulouse · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
35
Ages
1 Month to 6 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 205 studies in Premature Birth with a site in France — 40 open to participants now, 46 under way, 2 of them phase 3. Premature Birth · France.

Planned enrollment
83rd of 99
35 · median 130
Started
2025
with 10 others
Observational
99 of 205
21 open now
Primary completion
2026-12
later than 21 of 45 live
Registered
195th of 205
by date

Among the 205 studies in Premature Birth with a site in France, this one is the 83rd largest by planned enrollment of the 99 observational ones that give a count, is one of 11 that started in 2025, is one of 99 observational ones, reaches primary completion later than 21 of the 45 other live ones, and was the 195th registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

40 of the 205 studies in Premature Birth with a site in France are open now. Recruiting first, the newest first:

35 more — sign in →

All 40 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 1 Month to 6 Months · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 205 studies in Premature Birth with a site in France, or all of them as a file.
02

Study summary

The research concerns the study of the interprofessional reproducibility of a grid for observing the development of premature infants from 1 to 6 months corrected age. No tool is available to characterize the mechanisms of early developmental processes and their deviations. We propose an analytical observation grid of developmental mechanisms in the first few months, in order to identify warning signs of developmental deviations and help define the nature and type of early care for vulnerable infants.

Read the detailed description

Improving the development of premature babies is a challenge. Developmental disabilities are common. Brain damage accounts for only a small proportion of disorders. Other factors have a major influence on the outcome: immaturity, an intrusive and stressful hospital environment, and parental socio-psychological conditions. Early sensory-motor disorders disrupt development. The high degree of cerebral plasticity in infants means that early care is essential if developmental trajectories are to be improved. Intervention programmes are heterogeneous. Meta-analyses therefore make only limited comparisons. The cognitive and behavioural benefits are variable. Motor benefits are low. No tools are available to determine the mechanisms of early developmental processes.

The SPIN-NA grid is a scale for analytical observation of developmental processes from 1 to 6 months corrected age to identify early warning signs and determine early care (nature, areas of care, objectives). The aim is to study the inter-professional reproducibility of the grid. This validation stage is essential if the grid is to serve as a reference tool in psychomotricity for vulnerable newborns.

Premature babies born between 27 and 32 gestational weeks will be assessed using the SPIN-NA grid by 5 experienced psychomotor-therapists, on the basis of videos taken at home between 1 and 6 months corrected age, by the creators of the grid. Each child was filmed only once. The inter-observer agreement should be at least 70% for the 8 observation axes defined in the SPIN-NA grid.

03

Conditions studied

  • Prematurity

Browse trials for

Keywords

  • Premature infant
  • early development
  • early care intervention
  • early evaluation
04

Who can participate

Ages eligible
1 Month to 6 Months
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants will be selected from infants born and hospitalized in the neonatology department of Toulouse University Hospital. The study targets a local population, with families residing within a 15-kilometer radius of Toulouse to allow for home-based video recording.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female child born between 27 and 32 weeks of amenorrhea in a singleton pregnancy;
  • Child hospitalized in the neonatology unit of Toulouse University Hospital;
  • Family home within a 15 km radius of Toulouse to allow for home visits for filming;
  • Parents with parental authority affiliated with a social security scheme or equivalent;
  • Signature of the form by the parents with parental authority
  • Absence of serious illness, as defined in the exclusion criteria;
  • The child may participate in another study during the duration of this study, without an exclusion period.

Exclusion criteria

Exclusion Criteria:

  • Child with a severe organic pathology detected during hospitalization and requiring specific and appropriate care for the diagnosed pathology;
  • Child with a neurological complication: Grade 3 or 4 intraventricular hemorrhage, periventricular cavitary leukomalacia, excluding frontal leukomalacia;
  • Child with a malformation or multiple malformations that impair the neurological prognosis;
  • Child with genetic or metabolic diseases;
  • Fetal alcohol syndrome;
  • Parental authority holders under guardianship, curatorship, or legal protection;
  • Any family condition that prevents compliance with the procedures set out in the study protocol, in the opinion of the investigator.
  • Family members who do not speak French fluently, in order to ensure understanding of the system and the proposed care.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
35 participants (estimated)
Patient registry
No

Groups and cohorts

  • SPIN-NA Evaluation

    Infants evaluated by SPIN-NA grid

    Other: SPIN-NA Developmental Observation Grid Assessment via Home-Based Standardized Video Recording

Interventions

  • OtherSPIN-NA Developmental Observation Grid Assessment via Home-Based Standardized Video Recording

    The SPIN-NA intervention consists of an analytical assessment of development using a standardized clinical observation grid. Infants are filmed at home once between 1 and 6 months of corrected age in their family environment by the creators of the grid. The filmed observation includes structured observation scenarios designed to assess eight areas of development: stress signals, physiological and tonic regulation, perceptual abilities of different sensory channels, exploratory appetite, manipulative activities, child interactions and communication, emotional expressions and expressiveness, parent-child interactions: parental adaptation to the child's behavior.The videos are evaluated independently by five experienced psychomotor therapists trained together in the use of the SPINNA grid. No treatment or physical intervention is administered; the intervention is observational and non-invasive, aimed at validating the reproducibility of the grid in a real-world context.

06

What researchers measure

Primary outcomes

  1. Inter-Rater Agreement on Developmental Difficulties Detection Using the SPIN-NA Grid Across 8 Observation Axes

    The primary outcome is the overall percentage of agreement between raters, calculated as the mean of agreement rates across all evaluator pairs. Agreement is defined as both raters assigning the same classification (presence or absence of anomaly) to a given infant for a given axis.

    Time frame: At the day 1 corresponding to the home video recording

Secondary outcomes

  1. Inter-Rater Agreement on SPIN-NA Grid Evaluations by Age Group at the time of evaluation : 1-3 Months vs. 4-6 Months Corrected Age

    Inter-rater agreement will be assessed separately for two age groups of infants: 1-3 months and 4-6 months corrected age. Each of the five trained psychomotor therapists will independently evaluate all infants in both age groups using the SPIN-NA grid. For each developmental axis, agreement is defined as two raters assigning the same classification (presence or absence of anomaly) to the same child. Agreement will be expressed as the mean percentage of agreement across all evaluator pairs for each age group. This analysis aims to explore whether the reproducibility of SPIN-NA assessments varies depending on the infant's age at the time of observation.

    Time frame: At the day 1 corresponding to the home video recording

07

Study locations

1 site
  • Intensive care /neonatology Toulouse Hospital
    Toulouse, 31000, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2025; primary completion for Dec 2026, 12 months later.

Of 373 non-industry observational studies under Premature Birth, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 63. This study's planned 12 months is below that.

Counting every sponsor, half of 388 studies reached it within 35 months; a quarter within 19 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 1, 2025
First posted
Sep 11, 2025
StartEst.
Dec 22, 2025
Primary completionEst.
Dec 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Dec 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07169110
Responsible party
Sponsor
First posted
Sep 11, 2025
Start date
Dec 22, 2025 (estimated)
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Dec 18, 2025

Study contacts

Nadège Algans
Contact
algans.n@chu-toulouse.fr
0561777204 ext. +33
Corine Alberge
study director · University Hospital of Toulouse
Nathalie Noack
study director · University Hospital of Toulouse

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion